Keyrus Biopharma, a contract research organization operating in Europe and part of the Keyrus Group, has standardized on Oracle Clinical and Oracle Databaseto help increase efficiency in clinical trial data collection, improve data quality and security, and support the organization’s European expansion plans.
“As a mid-size organization, we needed a reliable, but easy-to-implement clinical data management system,” said Olivier Perrot, Head of Data Management, Keyrus Biopharma.
With Oracle Clinical, Keyrus Biopharma hopes to gain greater flexibility in designing clinical trials and managing data collection, as well as increased scalability to support business expansion. The solution provides comprehensive data validation capabilities – through a library of reusable procedures based on Clinical Data Acquisition Standards Harmonization (CDash) and Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM) standards.
Keyrus Biopharma worked with Pharmasol, an Oracle Gold Partner, and used Pharmasol RapidLive to accelerate the deployment cycle.
“Rapidly growing contract research organizations, like Keyrus Biopharma, require flexible and scalable health sciences applications that help them to accelerate the clinical trial process while navigating an increasingly complex regulatory environment,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.